Search Results - "COVAD Study Group"

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.

Authors: Palazzo, Leonardo Lindblom, Julius Kihlgren Olsson, Emelie et al.

Source: Rheumatology International. Oct2024, Vol. 44 Issue 10, p1923-1933. 11p.

COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.

Authors: Alunno, Alessia Carubbi, Francesco Tan, Ai Lyn et al.

Source: Rheumatology International. Sep2024, Vol. 44 Issue 9, p1725-1731. 7p.

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.

Authors: Panchawagh, Suhrud Ravichandran, Naveen Barman, Bhupen et al.

Source: Rheumatology International. Jan2024, Vol. 44 Issue 1, p73-80. 8p.

Abstract 167: COVID-19 vaccine side effects in Type 1 diabetes mellitus patients as compared to healthy controls: Results from the COVAD study.

Authors: Chatterjee, Tulika Naveen, R Gracia-Ramos, Abraham et al.

Source: Indian Journal of Endocrinology & Metabolism. ESICON 2022 Abstracts, Vol. 26, p71-71. 1p.

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus.

Authors: Dey M Doskaliuk B Lindblom J et al.

Source: Journal of clinical medicine [J Clin Med] 2023 Dec 07; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 07.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE